Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00054212" target="_blank" >RIV/00216224:14110/11:00054212 - isvavai.cz</a>
Alternative codes found
RIV/00209805:_____/11:#0000156
Result on the web
<a href="http://dx.doi.org/10.4021/wjon385w" target="_blank" >http://dx.doi.org/10.4021/wjon385w</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4021/wjon385w" target="_blank" >10.4021/wjon385w</a>
Alternative languages
Result language
angličtina
Original language name
Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors
Original language description
Recently, it has been reported that central administration of agouti-related peptide (AgRP) might have protective effect against cachexia development in tumor-bearing mice. In this study, we determined whether the disease-free endometrial cancer survivors present with different plasma AgRP levels than controls and whether there was an association with the duration of the disease- free interval. The total of 53 endometrial cancer survivors was enrolled in the study along with 93 healthy control women ofsimilar age. Fasting blood samples were obtained and AgRP plasma levels determined using ELISA-based methodology. The AgRP plasma levels were signifi cantly higher in the cases than in the controls; AgRP levels were the lowest in obese control women; onthe contrary, the AgRP plasma levels were highest in non-obese cancer survivors.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/ED2.1.00%2F03.0101" target="_blank" >ED2.1.00/03.0101: Regional Centre for Applied Molecular Oncology (RECAMO)</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
World Journal of Oncology
ISSN
1920-4531
e-ISSN
—
Volume of the periodical
2
Issue of the periodical within the volume
5
Country of publishing house
CA - CANADA
Number of pages
6
Pages from-to
232-237
UT code for WoS article
—
EID of the result in the Scopus database
—